Bone and Mineral Diagnostic Testing Market Report 2026

Bone and Mineral Diagnostic Testing Market Overview

• Bone and Mineral Diagnostic Testing market size has reached to $1.14 billion in 2025 • Expected to grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Rising Incidence Of Bone-Related Diseases To Drive Growth In The Bone and Mineral Diagnostic Testing Market • Market Trend: Cutting-Edge Vitamin D Test For Enhanced Well-Being And Market Leadership • North America was the largest region in 2025.

What Is Covered Under Bone and Mineral Diagnostic Testing Market?

A bone and mineral diagnostic test is a medical treatment that determines the quantity of calcium and other minerals in a section of bone. This test is used to detect bone loss and osteoporosis, monitor osteoporosis therapy, and assess the risk of fractures. The main products of bone and mineral diagnostic testing are assays or consumables and instruments. An assay is a laboratory process for assessing the presence, quantity, or function activity of a target element in a qualitative or quantitative manner. It is employed in medicine, mining, pharmacy, and numerous branches of biology. Bone and mineral diagnostic testing is used for tests such as enzyme-linked immunosorbent assay (ELISA), clinical laboratory improvement amendments (CLIA), and others, applied in vitamin D testing and bone metabolism.

What Is The Bone and Mineral Diagnostic Testing Market Growth Forecast?

The bone and mineral diagnostic testing market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing focus on preventive bone health management, rising adoption of ai-assisted diagnostic tools, expansion of outpatient diagnostic services, growing demand for early disease detection, increasing investments in advanced diagnostic platforms. Major trends in the forecast period include increasing adoption of advanced bone density testing systems, rising use of vitamin d and bone metabolism assays, growing integration of automated diagnostic instruments, expansion of preventive osteoporosis screening, enhanced focus on early fracture risk assessment.

Global Bone and Mineral Diagnostic Testing Market Segmentation

1) By Product: Assays Or Consumables, Instruments 2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types 3) By Application: Vitamin D Testing, Bone Metabolism Subsegments: 1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards 2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices

What Is The Driver Of The Bone and Mineral Diagnostic Testing Market?

An increase in the incidence of bone-related diseases is expected to propel the growth of the bone and mineral diagnostic testing market going forward. Bone-related diseases are ailments that alter the strength or flexibility of bones, making them weaker and more prone to fractures, and can cause symptoms such as bone pain, trouble moving, and an increased risk of bone fractures. Bone and mineral diagnostic tests, such as bone density tests, can assist in preventing bone diseases by identifying low bone density before osteoporosis grows, forecasting the risk of future fractures, and tracking the efficacy of ongoing osteoporosis treatment. The increasing incidence of bone-related diseases, coupled with growing awareness and technological advancements, is expected to fuel the growth of the bone and mineral diagnostic testing market. For instance, in July 2025, the Institute for Health Transformation, an Australia-based nonprofit research institute, posted that by 2033, 7.7 million Australians aged 50 years and older are predicted to have osteoporosis and osteopenia, an increase of 23% from 2023. Therefore, an increase in the incidence of bone-related diseases will drive the bone and mineral diagnostic testing industry.

Key Players In The Global Bone and Mineral Diagnostic Testing Market

Major companies operating in the bone and mineral diagnostic testing market are Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Epitope Diagnostics Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, EKF Diagnostics, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Beammed Ltd., Medonica Co. Ltd.

Global Bone and Mineral Diagnostic Testing Market Trends and Insights

Major companies operating in the bone and mineral diagnostic testing market are focusing on innovative solutions such as Vitamin D Test to strengthen their position in the market. A Vitamin D test refers to a blood test that measures the level of vitamin D in your blood. Vitamin D is a crucial nutrient that plays a vital role in maintaining bone health, supporting the immune system, and regulating various other physiological processes. For instance, in February 2023, Hurdle, a brand under Chronomics Inc., announced the general availability of their Vitamin D Test. This test measures the amount of 25-hydroxyvitamin D, an indicator for the level of Vitamin D in the body. It is involved in regulating calcium and maintaining overall health. The test is available through various providers, including Quest Diagnostics, and can be conducted through in-person sample collection or at-home test kits.

What Are Latest Mergers And Acquisitions In The Bone and Mineral Diagnostic Testing Market?

In November 2024, Echolight S.p.A., an Italy-based high-tech biomedical company, announced a multi year agreement with Siemens Healthineers to advance bone and mineral diagnostic testing. Through this deal, Siemens Healthineers will resell Echolight’s REMS (Radiofrequency Echographic Multi Spectrometry) devices to expand its women’s health portfolio and enhance osteoporosis diagnosis and monitoring, enable better fracture-risk prediction, and strengthen Siemens Healthineers’ offering in bone and mineral diagnostic testing for hospitals and clinics. Siemens Healthineers is a Germany-based medical technology company that develops and sells medical imaging and laboratory diagnostics and provides related services for hospitals and clinical laboratories.

Regional Outlook

North America was the largest region in the bone and mineral diagnostic testing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bone and Mineral Diagnostic Testing Market?

The bone and mineral diagnostic testing market includes revenues earned by entities by testing services such as bone mineral density (BMD) tests (bone densitometry) and bone scans (skeletal scintigraphy). The market value includes the value of related goods sold by the service provider or included within the service offering. The bone and mineral diagnostic testing market also includes sales of computed tomography scans (CT scans), magnetic resonance imaging (MRI), radionuclide bone scans, and bone biopsies, which are used in providing bone and mineral diagnostic testing services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bone and Mineral Diagnostic Testing Market Report 2026?

The bone and mineral diagnostic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bone and mineral diagnostic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.